logo
welcome
ScienceDaily

ScienceDaily

Genomic tug of war could boost cancer therapy

ScienceDaily
Summary
Nutrition label

76% Informative

Wilmot Cancer Institute researchers have uncovered a "g myeloid tug of war" in animal studies that could influence how well certain patients respond to decitabine.

H2A.Z binds DNA loosely, helping to turn on nearby genes, helping the ca Wilmot Cancer Institute pes of cancer have very high levels of H2a.Z, which may help them overcome this drug's effects.

The same effect was seen with a toxic chemical, called TDCIPP, which is widely used in flame retardant Development, Wilmot span class="summaryFeed_highLightText__NxlGi">Meng Murphy first Murphy TDCIPP TDCIPP Two years ago t__NxlGi">Meng Murphy Patrick Murphy me PhD l Health Science CenterBiomedical Genetics "summaryFeed_hig the University of Rochester Medical Center s="summaryFeed_ Wilmot's Genetics, Epigenetics span> first PhD Fanju Meng Murphy

VR Score

87

Informative language

94

Neutral language

47

Article tone

informal

Language

English

Language complexity

55

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links